InMed Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
InMed Pharmaceuticals Total Assets Growth & History (INM)
InMed Pharmaceuticals's total assets was $15.6M for fiscal 2025.
View full InMed Pharmaceuticals company overviewInMed Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $15.6M | $3.8M | +31.78% |
| 2024 | 2024-06-30 | $11.8M | −$2.3M | −16.19% |
| 2023 | 2023-06-30 | $14.1M | $1.3M | +10.31% |
| 2022 | 2022-06-30 | $12.8M | $3.0M | +30.74% |
| 2021 | 2021-06-30 | $9.8M | $2.0M | +25.36% |
| 2020 | 2020-06-30 | $7.8M | — | — |
InMed Pharmaceuticals quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $9.1M | −$146,028 | −1.57% |
| Q2 2026 | 2025-12-31 | $11.2M | $2.7M | +31.63% |
| Q1 2026 | 2025-09-30 | $13.4M | $2.9M | +27.67% |
| Q4 2025 | 2025-06-30 | $15.6M | $3.8M | +31.78% |
| Q3 2025 | 2025-03-31 | $9.3M | — | — |
| Q2 2025 | 2024-12-31 | $8.5M | −$6.8M | −44.27% |
| Q1 2025 | 2024-09-30 | $10.5M | −$452,233 | −4.14% |
| Q4 2024 | 2024-06-30 | $11.8M | −$2.3M | −16.19% |
| Q2 2024 | 2023-12-31 | $15.3M | −$1.7M | −9.84% |
| Q1 2024 | 2023-09-30 | $10.9M | −$3.7M | −25.14% |
| Q4 2023 | 2023-06-30 | $14.1M | $1.3M | +10.31% |
| Q3 2023 | 2023-03-31 | $14.7M | −$755,696 | −4.88% |
| Q2 2023 | 2022-12-31 | $16.9M | −$2.5M | −12.71% |
| Q1 2023 | 2022-09-30 | $14.6M | −$2.7M | −15.83% |
| Q4 2022 | 2022-06-30 | $12.8M | $3.0M | +30.74% |
| Q3 2022 | 2022-03-31 | $15.5M | $3.1M | +25.44% |
| Q2 2022 | 2021-12-31 | $19.4M | $7.6M | +65.00% |
| Q1 2022 | 2021-09-30 | $17.3M | $10.7M | +162.39% |
| Q4 2021 | 2021-06-30 | $9.8M | $2.0M | +25.36% |
| Q3 2021 | 2021-03-31 | $12.3M | — | — |
| Q2 2021 | 2020-12-31 | $11.7M | — | — |
| Q1 2021 | 2020-09-30 | $6.6M | — | — |
| Q4 2020 | 2020-06-30 | $7.8M | — | — |
InMed Pharmaceuticals total assets trends
Over the last five fiscal years, InMed Pharmaceuticals's total assets increased from $7.8M to $15.6M, a change of $7.8M. The latest reported quarter, Q3 2026, shows $9.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InMed Pharmaceuticals source filings ↗